The regulatory approval bolsters the hashish firm’s ambitions to be a prime participant within the class.
Tilray (NASDAQ:TLRY) has opened a brand new marketplace for its medical marijuana. The corporate introduced Monday that Portugal’s nationwide healthcare regulator, Infarmed, has granted it authorization to promote its merchandise in that nation.
“That is the primary time a full high quality file was required and delivered to acquire market authorization in Europe for a medical hashish product,” Tilray wrote within the press launch trumpeting the information.
– Learn the whole article at The Motley Fool.